You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

King Pharms Llc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for KING PHARMS LLC, and what generic and branded alternatives to KING PHARMS LLC drugs are available?

KING PHARMS LLC has twelve approved drugs.

Summary for King Pharms Llc

US Patents:	0
Tradenames:	12
Ingredients:	11
NDAs:	12

Drugs and US Patents for King Pharms Llc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms Llc	BICILLIN C-R	penicillin g benzathine; penicillin g procaine	INJECTABLE;INJECTION	050138-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
King Pharms Llc	SILVADENE	silver sulfadiazine	CREAM;TOPICAL	017381-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-005	Dec 18, 2008		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
King Pharms Llc	PENICILLIN G PROCAINE	penicillin g procaine	INJECTABLE;INJECTION	060101-001	Approved Prior to Jan 1, 1982		RX	No	Yes		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for King Pharms Llc

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms Llc	ALTACE	ramipril	CAPSULE;ORAL	019901-003	Jan 28, 1991	7,368,469	⤷ Subscribe
King Pharms Llc	AVINZA	morphine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021260-006	Dec 18, 2008	6,066,339	⤷ Subscribe
King Pharms Llc	ALTACE	ramipril	CAPSULE;ORAL	019901-002	Jan 28, 1991	4,587,258	⤷ Subscribe
King Pharms Llc	INTAL	cromolyn sodium	SOLUTION;INHALATION	018596-001	May 28, 1982	3,975,536	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for KING PHARMS LLC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	45 mg and 75 mg	➤ Subscribe	2009-07-30
➤ Subscribe	Extended-release Capsules	30 mg, 60 mg, 90 mg and 120 mg	➤ Subscribe	2007-06-04

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.